Studies on prostate cancers showed that binding of androgen to AR in the cytoplasm may initiate signal transduction pathways to regulate cellular proliferation and migration, known as non-genomic pathway, that requires neither AR nuclear translocation nor DNA binding [11–13]. This evidence concerns the gene AR and prostate carcinoma.